Advances in Radionuclide Production and Their Applications in Therapeutic Radiopharmaceuticals
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Radiopharmaceutical Sciences".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 73
Special Issue Editor
2. Faculty of Pharmacy, Université Laval, Quebec, QC, Canada
Interests: cyclotron production of medical isotopes; nuclear and radiochemistry; radiopharmacology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiopharmaceutical therapy has gained widespread recognition in the last several years, prompted in part by the approval of several novel radiopharmaceuticals for cancer treatment. Interest in therapeutic radionuclides and radiopharmaceuticals is growing as never before, making it a vibrant area of research in the rapidly evolving landscape of nuclear medicine. Isotopes of actinium, astatine, bismuth, copper, indium, lanthanum, lead, lutetium, radium, rhenium, scandium, terbium, yttrium, etc., each with their own characteristics, add to the arsenal of tools used to diagnose and treat diseases.
This Special Issue, entitled “Advances in Radionuclide Production and Their Applications in Therapeutic Radiopharmaceuticals", will focus on the latest advances in the production of radionuclides for use in medicine and innovations in the research and development of radiopharmaceuticals with therapeutic potential. This Special Issue welcomes original research articles and up-to-date review papers on topics such as novel radiochemistry; the production of radionuclides using cyclotrons, accelerators, or reactors and the specifics of target development; radionuclide generators; radiolabelled small molecules, peptides, antibodies, and nanocarriers; radiobiology and mechanistic studies; clinical translation and the complementary role of imaging; strategies to potentiate the therapeutic effect of radiopharmaceuticals; the quality, regulatory, logistics, and radiation safety concerns involved in large-scale radionuclide production; and other practical aspects and future directions for therapeutic radionuclides and radiopharmaceuticals.
Dr. Svetlana Selivanova
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiopharmaceutical sciences
- radiochemistry
- radiopharmacology
- radionuclide production
- molecular imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
